Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Qutenza

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • Prescrire international
  • 2017
  • Corpus ID: 73417334
 
Is this relevant?
2015
2015
OBJECTIVES Qutenza is a high-dose capsaicin patch used to relieve neuropathic pain from postherpetic neuralgia (PHN) and HIV… Expand
Is this relevant?
2014
2014
INTRODUCTION Qutenza (capsaicin) 8% patch is used to treat various neuropathic indications, including postherpetic neuralgia (PHN… Expand
Is this relevant?
2013
2013
Qutenza® is a capsaicin patch used to treat peripheral neuropathic pain, including postherpetic neuralgia (PHN) and human… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2013
2013
BACKGROUND Treatment of chronic pain conditions is commonly assessed at specific endpoints at preset times during or after… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Qutenza is a high potency capsaicin topical patch which has been recommended for the treatment of peripheral neuropathic pain… Expand
Is this relevant?
2012
2012
The diagnosis and the management of neuropathic pain still remain challenging. The main reason for these is the variety of… Expand
Is this relevant?
2011
2011
  • The Medical letter on drugs and therapeutics
  • 2011
  • Corpus ID: 9055297
The FDA has approved a topical 8% patch formulation of capsaicin (Qutenza-NeurogesX), available only by prescription, for local… Expand
Is this relevant?
Review
2011
Review
2011
ABSTRACT Qutenza is a high-potency capsaicin (8%) topical patch, labeled for treating pain associated with postherpetic neuralgia… Expand
Is this relevant?
2010
2010
Patients recorded their ‘average pain for the past 24 hours’ using the Numeric Pain Rating Scale (NPRS) daily. The proportion of… Expand
Is this relevant?